Skip to content

Clinical trials

Genetic Diseases, Inborn trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Brazil Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20131
20142
20151
20172
20181
20202
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical4
PTC Therapeutics3
Kastle Therapeutics, LLC2
Alexion Pharmaceuticals, Inc.1
Azafaros B.V.1
Friedreich's Ataxia Research Alliance1
Intellia Therapeutics1
Pfizer1
Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn15
Nervous System Diseases6
Metabolic Diseases5
Metabolism, Inborn Errors5
Blood Coagulation Disorders4
Blood Coagulation Disorders, Inherited4
Coagulation Protein Disorders4
Hematologic Diseases4
Hemophilia A4
Hemorrhagic Disorders4

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.